I read with great interest the article by Tapson et al,1 titled “Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines.” This excellent review indicates that despite published recommendations by experts in cardiovascular and orthopedic surgery practice, there are still a significant number of patients who are not receiving antithrombotic therapy and as a result are at risk of stroke, deep vein thrombosis, and pulmonary embolism. The adoption and use of protocols guiding the use of antithrombotic agents in these patient populations should result in an increased use of these drugs with a corresponding decrease in morbidity and mortality.
Fricker MP. Antithrombotic Therapy: A Tool to Assess Your Practices. Arch Intern Med. 2006;166(1):126. doi:10.1001/archinte.166.1.126-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: